A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

NCT03009214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: AMC303

Sponsor

amcure GmbH